Segall Bryant & Hamll Intl Eq Retl holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Segall Bryant & Hamill International Equity Fund - Retail Class CIQRX
- NAV / 1-Day Return 15.99 / +0.76 %
- Total Assets 15.9M
-
Adj. Expense Ratio
0.990%
- Expense Ratio 1.040%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.19%
- Turnover 107%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:25 AM GMT+0
Morningstar’s Analysis CIQRX
Will CIQRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Roche Holding AG Ordinary Shares new | 2.22 | 349,626 | Healthcare |
ASML Holding NV | 2.14 | 335,900 | Technology |
Banco Bilbao Vizcaya Argentaria SA | 1.61 | 252,471 | Financial Services |
Novartis AG Registered Shares | 1.54 | 241,701 | Healthcare |
BP PLC | 1.49 | 233,772 | Energy |
BNP Paribas Act. Cat.A | 1.45 | 227,220 | Financial Services |
GSK PLC | 1.43 | 224,098 | Healthcare |
Kioxia Holdings Corp Ordinary Shares | 1.38 | 216,432 | Technology |
NatWest Group PLC | 1.27 | 199,109 | Financial Services |
Nomura Holdings Inc | 1.20 | 188,357 | Financial Services |